Stephen McLean has served on Certara's board since 2013 and is an Arsenal Capital Partners designee under the company's Stockholders Agreement, serving on the Nominating and Corporate Governance Committee. He has been a Partner at Arsenal Capital Partners, a healthcare- and industrial-focused private equity firm, since 2010, and co-founded Merrill Lynch Capital Partners in 1984. He currently sits on the boards of private companies including WCG Clinical, CellCarta and 3DR Labs, and holds a B.S. in Economics and an MBA from the Wharton School of the University of Pennsylvania.